163 related articles for article (PubMed ID: 36057637)
1. Ischemia and reperfusion injury combined with cisplatin induces immunogenic cell death in lung cancer cells.
Zhang S; Li Y; Liu S; Ma P; Guo M; Zhou E; Duan L; Fan J; Liao T; Tan Q; Wang X; Wu F; Jin Y
Cell Death Dis; 2022 Sep; 13(9):764. PubMed ID: 36057637
[TBL] [Abstract][Full Text] [Related]
2. Damage-associated molecular patterns (DAMPs) related to immunogenic cell death are differentially triggered by clinically relevant chemotherapeutics in lung adenocarcinoma cells.
Solari JIG; Filippi-Chiela E; Pilar ES; Nunes V; Gonzalez EA; Figueiró F; Andrade CF; Klamt F
BMC Cancer; 2020 May; 20(1):474. PubMed ID: 32456685
[TBL] [Abstract][Full Text] [Related]
3. EHD1 confers resistance to cisplatin in non-small cell lung cancer by regulating intracellular cisplatin concentrations.
Gao J; Meng Q; Zhao Y; Chen X; Cai L
BMC Cancer; 2016 Jul; 16():470. PubMed ID: 27411790
[TBL] [Abstract][Full Text] [Related]
4. An ER-Targeting Iridium(III) Complex That Induces Immunogenic Cell Death in Non-Small-Cell Lung Cancer.
Wang L; Guan R; Xie L; Liao X; Xiong K; Rees TW; Chen Y; Ji L; Chao H
Angew Chem Int Ed Engl; 2021 Feb; 60(9):4657-4665. PubMed ID: 33217194
[TBL] [Abstract][Full Text] [Related]
5. Tannins in Phyllanthus emblica L. improves cisplatin efficacy in lung cancer cells by boosting endoplasmic reticulum stress to trigger immunogenic cell death.
Hu Q; Wang S; Cheng R; Liu Y; Chang Z; Huang Y; Chen Y; Luo X; Zhou L; Wang B; Gao Y; Chen H; Liu R; Zhang L
Phytomedicine; 2024 Jan; 123():155219. PubMed ID: 38056150
[TBL] [Abstract][Full Text] [Related]
6. Decreased MicroRNA-26a expression causes cisplatin resistance in human non-small cell lung cancer.
Yang Y; Zhang P; Zhao Y; Yang J; Jiang G; Fan J
Cancer Biol Ther; 2016 May; 17(5):515-25. PubMed ID: 26492332
[TBL] [Abstract][Full Text] [Related]
7. Gambogic acid synergistically potentiates cisplatin-induced apoptosis in non-small-cell lung cancer through suppressing NF-κB and MAPK/HO-1 signalling.
Wang LH; Li Y; Yang SN; Wang FY; Hou Y; Cui W; Chen K; Cao Q; Wang S; Zhang TY; Wang ZZ; Xiao W; Yang JY; Wu CF
Br J Cancer; 2014 Jan; 110(2):341-52. PubMed ID: 24300974
[TBL] [Abstract][Full Text] [Related]
8. Synergistic anticancer effect of combined use of Trichosanthes kirilowii with cisplatin and pemetrexed enhances apoptosis of H1299 non-small-cell lung cancer cells via modulation of ErbB3.
Ku JM; Hong SH; Kim HI; Kim MJ; Kim SK; Kim M; Choi SY; Park J; Kim HK; Kim JH; Seo HS; Shin YC; Ko SG
Phytomedicine; 2020 Jan; 66():153109. PubMed ID: 31790894
[TBL] [Abstract][Full Text] [Related]
9. d-Borneol enhances cisplatin sensitivity via p21/p27-mediated S-phase arrest and cell apoptosis in non-small cell lung cancer cells and a murine xenograft model.
Li J; Yuan J; Li Y; Wang J; Gong D; Xie Q; Ma R; Wang J; Ren M; Lu D; Xu Z
Cell Mol Biol Lett; 2022 Jul; 27(1):61. PubMed ID: 35883026
[TBL] [Abstract][Full Text] [Related]
10. Restoration of the immunogenicity of cisplatin-induced cancer cell death by endoplasmic reticulum stress.
Martins I; Kepp O; Schlemmer F; Adjemian S; Tailler M; Shen S; Michaud M; Menger L; Gdoura A; Tajeddine N; Tesniere A; Zitvogel L; Kroemer G
Oncogene; 2011 Mar; 30(10):1147-58. PubMed ID: 21151176
[TBL] [Abstract][Full Text] [Related]
11. Lung-specific exosomes for co-delivery of CD47 blockade and cisplatin for the treatment of non-small cell lung cancer.
Cui Z; Ruan Z; Zeng J; Sun J; Ye W; Xu W; Guo X; Zhang L; Song L
Thorac Cancer; 2022 Oct; 13(19):2723-2731. PubMed ID: 36054073
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo inhibitory effect of the combination of Wenxia Changfu formula [see text] with cisplatin in non-small cell lung cancer.
Ji XM; Ouyang B; Liu H; Liu GW; Wu ZC; Yu HY; Wang CY; Wang ZX; Wang WP
Chin J Integr Med; 2011 Dec; 17(12):908-16. PubMed ID: 22139542
[TBL] [Abstract][Full Text] [Related]
13. Thymoquinone and cisplatin as a therapeutic combination in lung cancer: In vitro and in vivo.
Jafri SH; Glass J; Shi R; Zhang S; Prince M; Kleiner-Hancock H
J Exp Clin Cancer Res; 2010 Jul; 29(1):87. PubMed ID: 20594324
[TBL] [Abstract][Full Text] [Related]
14. Immune-dependent antineoplastic effects of cisplatin plus pyridoxine in non-small-cell lung cancer.
Aranda F; Bloy N; Pesquet J; Petit B; Chaba K; Sauvat A; Kepp O; Khadra N; Enot D; Pfirschke C; Pittet M; Zitvogel L; Kroemer G; Senovilla L
Oncogene; 2015 Jun; 34(23):3053-62. PubMed ID: 25065595
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic chemotherapeutic agents and the EGFR-TKI osimertinib induce calreticulin exposure in non-small cell lung cancer.
Furukawa R; Inoue H; Yoneshima Y; Tsutsumi H; Iwama E; Ikematsu Y; Ando N; Shiraishi Y; Ota K; Tanaka K; Nakanishi Y; Okamoto I
Lung Cancer; 2021 May; 155():144-150. PubMed ID: 33819860
[TBL] [Abstract][Full Text] [Related]
16. Synergistic interaction between cisplatin and PARP inhibitors in non-small cell lung cancer.
Michels J; Vitale I; Senovilla L; Enot DP; Garcia P; Lissa D; Olaussen KA; Brenner C; Soria JC; Castedo M; Kroemer G
Cell Cycle; 2013 Mar; 12(6):877-83. PubMed ID: 23428903
[TBL] [Abstract][Full Text] [Related]
17. Apigenin Enhanced Antitumor Effect of Cisplatin in Lung Cancer via Inhibition of Cancer Stem Cells.
Li Y; Chen X; He W; Xia S; Jiang X; Li X; Bai J; Li N; Chen L; Yang B
Nutr Cancer; 2021; 73(8):1489-1497. PubMed ID: 32757802
[TBL] [Abstract][Full Text] [Related]
18. Sequential Interferon β-Cisplatin Treatment Enhances the Surface Exposure of Calreticulin in Cancer Cells via an Interferon Regulatory Factor 1-Dependent Manner.
Yang PM; Hsieh YY; Du JL; Yen SC; Hung CF
Biomolecules; 2020 Apr; 10(4):. PubMed ID: 32326356
[TBL] [Abstract][Full Text] [Related]
19. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
[TBL] [Abstract][Full Text] [Related]
20. Clinically Relevant Chemotherapeutics Have the Ability to Induce Immunogenic Cell Death in Non-Small Cell Lung Cancer.
Flieswasser T; Van Loenhout J; Freire Boullosa L; Van den Eynde A; De Waele J; Van Audenaerde J; Lardon F; Smits E; Pauwels P; Jacobs J
Cells; 2020 Jun; 9(6):. PubMed ID: 32560232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
